Company intelligence / Profile preview

Nesos

Redwood City, California, United Statesnesos.org ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

The Vorso PROTECT System demonstrated safety and efficacy in a completed pilot study for patients with moderately to severely active rheumatoid arthritis who were naïve to biologic or synthetic DMARDs. The company has received FDA Breakthrough Device Designation and continues clinical development toward approval. Additional neurological/mental health assets are in earlier stages.

Therapeutic areas: ImmunologyNeurology
Modalities: DeviceNon-pharmacological therapy (digital therapeutic)Neuromodulation device
Industry: Therapeutic Medical Devices

Partnerships

Academic collaborations with Stanford UniversityVall d'Hebron Institute of ResearchHarvard UniversityMount Sinai Hospital (NY)Feinstein Institute for Medical Research at Northwell HealthUC San DiegoUCSF

Beyond the preview

Go deeper on Nesos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nesos.

Explore the full profile